International Ophthalmology Conference To Feature Ceragenix Pharmaceuticals, Inc.'s Anti-Microbial Technology

DENVER--(BUSINESS WIRE)--Ceragenix Pharmaceuticals, Inc. (OTCBB:CGXP) today announced that Dr. Paul B. Savage, a Reed M. Izatt Professor of Chemistry and Biochemistry at Brigham Young University (BYU), has been invited to present at the 1st Asia-ARVO meeting organized by the Singapore Eye Research Institute on March 2, 2007 in Singapore.

MORE ON THIS TOPIC